pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,561
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
lixosicone
lixosicone [INN]
Substance (Drug) Abuse
Aelis Farma SAS
0
catalysts
Phase 2
lonigutamab
lonigutamab [INN]
Graves' Ophthalmopathy
$ALMS
ALUMIS INC.
0
catalysts
Phase 2
lorigerlimab
Colorectal Cancer
$MGNX
MACROGENICS INC
0
catalysts
Phase 2
← prev
page 42 of 53
next →
131
Pain
89
Neurology
1
lucicebtide
Esophageal Cancer
Sapience Therapeutics Inc
0
catalysts
Phase 2
lucinactant
Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syn…
Lee's Pharmaceutical Holdings Ltd
0
catalysts
Phase 2
ludotadipep
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
FutureChem Co Ltd
0
catalysts
Phase 2
lufepirsen
Nexagon (lufepirsen [INN])
Persistent Corneal Epithelial Defects
Amber Ophthalmics Inc
0
catalysts
Phase 2
lumacaftor
Subarachnoid Hemorrhage
Cystic fibrosis transmembrane conductance regulator
Qanatpharma AG
0
catalysts
Phase 2
lunbotinib
lunbotinib [INN]
Non-Small Cell Lung Cancer
Ellipses Pharma Ltd
0
catalysts
Phase 2
luvesilocin
luvesilocin [INN]
Post Partum Depression (Maternal Depression / Postnatal Depression)
Reunion Neuroscience Inc
0
catalysts
Phase 2
luvixasertib
luvixasertib [INN]
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Treadwell Therapeutics Inc
0
catalysts
Phase 2
luvomeran
Cystic Fibrosis
$VERX
Vertex, Inc.
0
catalysts
Phase 2
luvometinib
luvometinib [INN]
Neurofibromatoses Type I (Von Recklinghausen's Disease)
Shanghai Fosun Pharmaceutical (Group) Co Ltd
0
catalysts
Phase 2
mRNA-3705
Methylmalonic Acidemia
$MRNA
Moderna, Inc.
0
catalysts
Phase 2
mRNA-3927
Propionic Acidemia
$MRNA
Moderna, Inc.
0
catalysts
Phase 2
mRNA-4359
Solid Tumor
$MRNA
Moderna, Inc.
0
catalysts
Phase 2
malaria [strain NF-54] vaccine 2
Malaria
Sanaria Inc
0
catalysts
Phase 2
margetuximab
Margenza (margetuximab-cmkb)
Gastric Cancer
Receptor tyrosine-protein kinase erbB-2
TerSera Therapeutics LLC
0
catalysts
Phase 2
maveropepimut-s
Fallopian Tube Cancer
$BVAXF
BioVaxys Technology Corp.
0
catalysts
Phase 2
mavrilimumab
Rheumatoid Arthritis
Granulocyte-macrophage colony-stimulating factor receptor
MedImmune Ltd
0
catalysts
Phase 2
mavrostobart
Solid Tumor
Phanes Therapeutics Inc
0
catalysts
Phase 2
mazindol ER
Quilience (mazindol)
Idiopathic Hypersomnia (IH)
Monoamine transporter
$NCEL
NewcelX Ltd.
0
catalysts
Phase 2
mebufotenin
mebufotenin [INN]
Treatment Resistant Depression
$ATAI
AtaiBeckley Inc.
0
catalysts
Phase 2
mecasermin rinfabate
Bronchopulmonary Dysplasia
Insulin-like growth factor 1 receptor
Chiesi Farmaceutici SpA
0
catalysts
Phase 2
mecbotamab vedotin
Non-Small Cell Lung Cancer
Tyrosine-protein kinase receptor UFO
Tubulin
$BCAB
BioAtla, Inc.
0
catalysts
Phase 2
meningococcal (pentavalent) vaccine
MenPenta
Neisseria meningitidis Infections
$SNY
Sanofi
0
catalysts
Phase 2
meplazumab
Ketantin
Malaria
Jiangsu Pacific Meinuoke Bio-Pharmarceutical Co Ltd
0
catalysts
Phase 2
metopimazine mesylate
Gastroparesis
Neurogastrx Inc
0
catalysts
Phase 2
metronidazole MR
metronidazole
Pouchitis
Avivia BV
0
catalysts
Phase 2
metyrosine
Metyrosine (metyrosine)
Autism Spectrum Disorder (ASD)
Tyrosine 3-monooxygenase
Yamo Pharmaceuticals LLC
0
catalysts
